Page 1 of 5

Launch of the standardised PARCA-R to assess cognitive and language development in two year olds

This week's The Lancet Child & Adolescent Health includes an article describing standardised scores for the Parent Report of Children's Abilities, Revised (PARCA-R) questionnaire. The PARCA-R is recommended for routine use in the UK to screen for developmental delay in children born preterm and can be completed by parents in 10 to 15 minutes.

A new website has also been lauched featuring an online version of the questionnaire and a pre-programmed calculator for deriving the standardised scores.

Dr Louise Linsell at NPEU collaborated with colleagues at the University of Leicester and other universities to standardise the scores.

We can now quantify a child’s developmental level relative to the UK population of two year olds, and identify advanced or delayed development. The standardised PARCA-R is freely available for parents to use and has been translated into 14 languages. It provides a reliable, cost-effective alternative to other developmental assessments that can be costly to administer.

NPEU at the Society for Clinical Trials 40th Annual Meeting

Stephen McCall and Associate Professor Ed Juszczak are presenting their work at this year's Society for Clinical Trials Annual Meeting in New Orleans, Louisiana this week.

They will talk about their work on an extension to the Consolidated Standards of Reporting Trials (CONSORT) which has been published in JAMA.

If you'll be in New Orleans please drop by and say hi.

New guidelines on reporting multi-arm parallel-group randomised trials

A special communication describing an extension to the Consolidated Standards of Reporting Trials (CONSORT) has been published in the Journal of the American Medical Association (JAMA). Led by NPEU CTU Director and Associate Professor Ed Juszczak, the extension aims to provide greater transparency and accuracy in reporting of such trials, to enhance understanding of the methodology and allow readers to accurately assess the conduct of a trial and interpret the results.

This extension to the CONSORT 2010 statement checklist will enhance the reporting of multi-arm trials, and has an important educational role in improving their conduct. It therefore covers the overlapping areas of multi-arm trial methodology and reporting.

Among the recommendations of the extension are that multi-arm trials be identified as such by the authors and that clear objectives and hypotheses referring to all the treatment groups be stated. If periods of recruitment and follow-up are different across groups, these should be explained, along with the statistical implications.

You can read about the CONSORT extension in JAMA.

BUMPES trial wins BMJ UK Research Paper of the Year 2018

The prestigious British Medical Journal (BMJ) have awarded the UK Research Paper of the Year 2018 to the BUMPES trial team. The BMJ Awards, now in its 10th year, showcases excellence and inspirational contributions in healthcare. The paperUpright versus lying down position in second stage of labour in nulliparous women with low dose epidural: BUMPES randomised controlled trial“, published in the BMJ in October 2017, was winner of the category which recognises new UK-based research which is likely to have a great impact on improving health and healthcare. The trial and writing committee, the Epidural and Position Trial Collaborative led by Professor Peter Brocklehurst, includes the NPEU Clinical Trials Unit director, Edmund Juszczak, senior trials statistician, Pollyanna Hardy, and senior health economist, Oliver Rivero-AriasRead more.

Page 1 of 5

Subscribe to this news feed